Shionogi and F2G report positive top line data from Phase III OASIS study
Publisher
ClinicalTrialsArena
Limited excerpt on-platform. Click anywhere on this card to open the original publisher in a new tab.
Canonical metadata stays public, while full text remains on the original site.